Stage I Multiple Myeloma Treatment (IFM-01-04).

Trial Profile

Stage I Multiple Myeloma Treatment (IFM-01-04).

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Mar 2012

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Mar 2012 Last checked against record.
    • 23 Mar 2012 Planned end date changed from 1 Nov 2009 to 1 Nov 2012 as reported by
    • 23 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top